What is the effect of adjusting epirubicin doses for body surface area?

Por Dobbs, N. A., Twelves, C. J.
Publicado em 1998

Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?

Por Dobbs, N. A., Twelves, C. J.
Publicado em 1998

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients

Por O'Byrne, K J, Dobbs, N, Harris, A L
Publicado em 2000

Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.

Por Heald, P. W., Perez, M. I., Christensen, I., Dobbs, N., McKiernan, G., Edelson, R.
Publicado em 1989

Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.

Por Johnson, P. J., Dobbs, N., Kalayci, C., Aldous, M. C., Harper, P., Metivier, E. M., Williams, R.
Publicado em 1992

Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.

Por Twelves, C. J., Dobbs, N. A., Michael, Y., Summers, L. A., Gregory, W., Harper, P. G., Rubens, R. D., Richards, M. A.
Publicado em 1992

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.

Por Twelves, C. J., Dobbs, N. A., Curnow, A., Coleman, R. E., Stewart, A. L., Tyrrell, C. J., Canney, P., Rubens, R. D.
Publicado em 1994

Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life.

Por Twelves, C. J., Dobbs, N. A., Lawrence, M. A., Ramirez, A. J., Summerhayes, M., Richards, M. A., Towlson, K. E., Rubens, R. D.
Publicado em 1994

Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.

Por Twelves, C. J., Porter, D. A., Lowry, M., Dobbs, N. A., Graves, P. E., Smith, M. A., Rubens, R. D., Richards, M. A.
Publicado em 1994

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

Por O'Byrne, K J, Dobbs, N, Propper, D J, Braybrooke, J P, Koukourakis, M I, Mitchell, K, Woodhull, J, Talbot, D C, Schally, A V, Harris, A L
Publicado em 1999

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

Por Jones, P H, Christodoulos, K, Dobbs, N, Thavasu, P, Balkwill, F, Blann, A D, Caine, G J, Kumar, S, Kakkar, A J, Gompertz, N, Talbot, D C, Ganesan, T S, Harris, A L
Publicado em 2004